A COMPARATIVE ASSESSMENT OF THE EFFECTIVE THERAPYWITH THE PREPARATION CONTAINING ANTIBODIES TO C-END FRAGMENTOF AT1-RECEPTOR OF ANGIOTENSIN II (CARDOSTAN) AND VALSARTAN (DIOVAN)
- 作者: Frolova EV1, Frolova EV1
-
隶属关系:
- 期: 卷 6, 编号 4 (2009)
- 页面: 88-90
- 栏目: Articles
- URL: https://journals.eco-vector.com/1994-9480/article/view/118077
- ID: 118077
如何引用文章
全文:
详细
At present the problem of investigation of new ways in treatment of arterial hypertension in combination with metabolic
syndrome and search for remedies able to influence on different symptoms of these diseases simultaneously is of great
importance. Cardostan regulates rennin-angiotensin-aldosteron system activity decreasing blood pressure, normalizes
lipid profile. It isn't inferior in hypotensive effect evidence to diovan treatment in dose of 80 mg a day singly. In addition the influence of diovan on lipid metabolism wasn't revealed.
syndrome and search for remedies able to influence on different symptoms of these diseases simultaneously is of great
importance. Cardostan regulates rennin-angiotensin-aldosteron system activity decreasing blood pressure, normalizes
lipid profile. It isn't inferior in hypotensive effect evidence to diovan treatment in dose of 80 mg a day singly. In addition the influence of diovan on lipid metabolism wasn't revealed.
参考
- Диагностика и лечение артериальной гипертензии. Российские рекомендации, третий пересмотр // Кардиоваскулярная терапия и профилактика. - 2008. - Т. 7, № 6. - С. 5, 15.
- Зернюкова Е. А., Петров В. И., Бакумов П. А. и др. // Материалы Российского национального конгресса кардиологов. - Томск, 2004. - С. 379.
- Мамедов М. Н., Косматова О. В., Чудакова И. В. и д р . // С ер д ц е. - 2 0 0 6 . - Т. 5 , № 3 (2 7 ) . - С. 1 2 9-1 3 3 .
- Подзолкова В. И., Брагина А. Е., Гладышева Е. А. // Системные гипертензии. - 2008. - № 4. - С. 37.
- Тыренко В. В., Богданов А. Н., Сысоева Н. Н. // Сердце. - 2008. - Т. 7, № 5. - С. 371-374.
- Aram V., et al. // Сердце. - 2003. - Т. 3. - С. 224-261.
补充文件
